Lucid Diagnostics Statistics
NASDAQ: LUCDHealth CareMedical/Dental InstrumentsUSD
0.3727-0.0136 (-3.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lucid Diagnostics by the numbers
Lucid Diagnostics has a market capitalization of $72.6 million based on 194.71M shares outstanding. With trailing EPS of $-0.36, Lucid Diagnostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.9% below its 50-day average and 61.4% below its 200-day average.
Average daily trading volume is 5.15M shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LUCD valuation vs. peer median
| Metric | LUCD | Peer median | Difference |
|---|---|---|---|
| Market cap | $72.57M | $62.73M | +16% |
| Avg. volume | 5.15M | 177.77K | +2798% |
Peer median across 8 companies: QTEX, SKIN, NYXH, LNSR, MBOT, APYX, DXR, SRTS.
Valuation
- Market cap
- $72.57M
- Price / sales (latest FY)
- 15.42
- EPS (TTM)
- $-0.36
- Shares outstanding
- 194.71M
Price and trading
- Previous close
- 0.3863
- Open
- 0.38
- Day range
- 0.3545 – 0.3946
- 52-week range
- 0.303 – 1.63
- 52-week change
- -64.67%
- 50-day moving average
- 0.5552
- 200-day moving average
- 0.9647
- Beta
- —
- Volume
- 2.26M
- Average volume
- 5.15M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 72.57M
- Forward Pe
- -2.23
- Eps
- -0.36
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.63
- Week52 Low
- 0.30
- Avg Volume
- 5.15M
- Shares Outstanding
- 194.71M
- Ma50
- 0.56
- Ma200
- 0.96
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -77.12%
- Pct From52w Low
- 23.00%